Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

Novel forms of IBD-related dysplasiaECCO'24 Stockholm
Year: 2024
Authors: Graham, Trevor
United Kingdom
Oral ritlecitinib and brepocitinib in patients with moderate to severe active Crohn’s Disease: Data from the PIZZICATO umbrella studyECCO'24 Stockholm
Year: 2024
Authors: Vermeire, Séverine
Belgium
Oxalyl-CoA decarboxylase is a major and specific virulence factor for Adherent Invasive Escherichia coliECCO'24 Stockholm
Year: 2024
Authors: Toumi, Eya
France
Personalized therapy in IBD: Hype or Reality?ECCO'24 Stockholm
Year: 2024
Authors: Vermeire, Séverine
Belgium
PINPOINT: The epidemiology of paediatric-onset Inflammatory Bowel Disease in the United Kingdom – a prospective, national, cohort study.ECCO'24 Stockholm
Year: 2024
Authors: Henderson, Paul
United Kingdom
Placing nutritional intervention in the IBD treatment algorithmECCO'24 Stockholm
Year: 2024
Authors: Halmos, Emma
Australia
Postoperative endoscopic recurrence after resection of Crohn’s terminal ileitis with Kono-S or side-to-side functional end anastomosis: results of a Multicenter Prospective Randomized TrialECCO'24 Stockholm
Year: 2024
Authors: Trencheva, Koianka
United States
Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine.ECCO'24 Stockholm
Year: 2024
Authors: Baldan-Martin, Montserrat
Spain
Pregnancy for IBD-patients with an enterostomy is feasible but is associated with complicationsECCO'24 Stockholm
Year: 2024
Authors: Bouwknegt, Dianne G.
The Netherlands
Prevalence and factors associated with Inflammatory Bowel Disease (IBD) activity during pregnancy: updated data from the DUMBO RegistryECCO'24 Stockholm
Year: 2024
Authors: Chaparro, María
Spain
Prevalence and severity of bowel urgency in Crohn’s Disease: Results from the Communicating Needs and Features of IBD Experience (CONFIDE) SurveyECCO'24 Stockholm
Year: 2024
Authors: Dubinsky, Marla C
United States
Prevalence of undiagnosed inflammatory Bowel Disease in patients with spondyloarthritis: EISER StudyECCO'24 Stockholm
Year: 2024
Authors: Gutiérrez Casbas, Ana
Spain
Primary efficacy and safety of mirikizumab in moderate to severe Crohn’s Disease: results of the treat-through VIVID 1 studyECCO'24 Stockholm
Year: 2024
Authors: Ferrante, Marc
Belgium
Proctocolectomy is associated with improved transplant-free survival in patients with primary sclerosing cholangitis: results from a pooled collaborative international studyECCO'24 Stockholm
Year: 2024
Authors: Mol, Bregje
The Netherlands
PROFILE: a multi-centre, randomised, open-label, biomarker-stratified clinical trial of treatment strategies for patients with newly-diagnosed Crohn’s diseaseECCO'24 Stockholm
Year: 2024
Authors: Noor, Nurulamin
United Kingdom
Programmable probiotic local delivery of anti-TNF-α nanobody to alleviate DSS-induced colitisECCO'24 Stockholm
Year: 2024
Authors: Kang, Guangbo
China
Promising efficacy of biologicals and small molecules for microscopic colitis: results from a large real-life multicenter cohortECCO'24 Stockholm
Year: 2024
Authors: Verstockt, Bram
Belgium
Resolution of inflammation - the next treatment target?ECCO'24 Stockholm
Year: 2024
Authors: Neurath, Markus Friedrich
Germany
Results of a pragmatic multicentred randomised controlled trial investigating the use of personalised golimumab dosing in Ulcerative Colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis)ECCO'24 Stockholm
Year: 2024
Authors: Doherty, Glen
Ireland
Risankizumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomised Phase 3 COMMAND StudyECCO'24 Stockholm
Year: 2024
Authors: Schreiber, Stefan Wolfgang
Germany